EVOLIS – Trademark Portfolio
Entity Type: 99
EVOLIS holds 26 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 25 filings in this category. The portfolio also extends into Class 37 (Building & Construction) across 6 Nice Classification classes. Currently, 13 trademarks are registered and 2 are pending. Notable registered marks include OMNEO, AGILIA, DUALYS, EDIKIO, and EVOLIS. The owner is based in BEAUCOUZE.
ZI Angers Beaucouze
14 avenue de la Fontaine
BEAUCOUZE F-49070 , FR
Showing of trademarks Trademarks
Trademark Classifications
EVOLIS's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does EVOLIS have?
EVOLIS has 26 U.S. trademarks filed with the USPTO. Of these, 13 registered, 2 pending, 1 abandoned, 1 cancelled.
What trademark classes does EVOLIS file in?
EVOLIS files trademarks across 6 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 37 (Building & Construction), Class 16 (Paper Goods), Class 42 (Computer & Scientific), Class 21 (Housewares). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are EVOLIS's most well-known trademarks?
EVOLIS's registered trademark portfolio includes well-known marks such as OMNEO, AGILIA, DUALYS, EDIKIO, and EVOLIS. These are among 13 currently registered trademarks in the portfolio.
What is EVOLIS's trademark registration success rate?
EVOLIS has a 87% trademark registration rate, with 13 out of 15 resolved applications resulting in successful registration. Currently, 2 applications are pending review.